Hematologic Diseases

The client’s pathologist must provide the cytogenetics report to Genoptix. COMPASS® Select includes the COMPASS® consultation report, clinical pathology evaluation, blood or bone marrow morphology (up to 20 stains and/or IHC antibodies), flow cytometry (up to 40 antibodies), and molecular tests as medically necessary.

disease state indication(s)
Hematological malignancies

clinical use
Intended use of test results by clinician: Diagnosis, Prognosis x Monitoring, Assessment of Risk. Various, case dependent.

methodology/product platform
Refer to individual tests and technologies

specimen type and requirements
Refer to individual tests for the most current specimen type and requirements

turnaround time
Global (TC & PC): 10 days

cpt code(s)
Refer to individual tests for CPT Code(s)

medicare moldx cpt code
Not applicable

regulatory classification
Refer to individual tests

ordering option
Global (TC & PC)